Table 1.

Patients: demographic characteristics

VariableTraitIL-2, n (%)IL-2 + vaccine, n (%)Total
TotalPatients305 (100)379 (100)684 (100)
SexMale190 (62)242 (64)432 (63)
Female115 (38)137 (36)252 (37)
RaceAsian1 (0)0 (0)1 (0)
Black3 (1)2 (1)5 (1)
White301 (99)377 (99)678 (99)
Age (y)11-205 (2)4 (1)9 (1)
21-3030 (10)29 (8)59 (9)
31-4076 (25)74 (20)150 (22)
41-5088 (29)131 (35)219 (32)
51-6079 (26)101 (27)180 (26)
61-7027 (9)39 (10)66 (10)
≥700 (0)1 (0)1 (0)
Eastern Cooperative Oncology Group score0242 (79)328 (87)570 (83)
157 (19)49 (13)106 (15)
26 (2)2 (1)8 (1)
Prior therapyNone2 (1)0 (0)2 (0)
Surgery300 (98)379 (100)679 (99)
Chemotherapy69 (23)97 (26)166 (24)
Radiotherapy50 (16)76 (20)126 (18)
Hormonal4 (1)32 (8)36 (5)
Immunotherapy185 (61)273 (72)458 (67)
Any 2 or more214 (70)301 (79)515 (75)
Any 3 or more72 (24)133 (35)205 (30)
ResponseComplete response12 (4)13 (3)25 (4)
Partial response27 (9)46 (12)73 (11)
None260 (85)317 (84)577 (84)